Deprescribing for frail older people - Learning from the case of Mrs. HansenGranas, A. G., Stendal Bakken, M., Ruths, S. & Taxis, K., Jun-2018, In : Research in Social and Administrative Pharmacy. 14, 6, p. 612-616 5 p.
Research output: Contribution to journal › Article › Academic › peer-review
Drug treatment is often an essential part in treatment and prevention of diseases in older people, but there is much concern about inappropriate medication use. This paper aims to describe the complexity of medication safety issues and clinical judgments when optimizing prescribing in older individuals. It uses the case of Mrs. Hansen, an aged nursing home resident, to illustrate the facilitators and barriers of this process. With decreasing life expectancy, medication use should shift from cure to care, focusing on symptomatic treatment to increase the patient's well-being. In Mrs. Hansen's case, the number of (potentially) dangerous medications were reduced, and non-pharmacological alternatives were considered. There were some medicines added, as underprescribing can also be a problem in older people. Deprescribing long-standing treatment can be interpreted by the patient and family as "giving up hope". More clinical evidence and practical communication tools are needed to guide deprescribing decisions, taking medical and patient-centered priorities into account. Studies evaluating such interventions should select outcome measures that are particularly relevant for frail old individuals. (c) 2017 Elsevier Inc. All rights reserved.
|Number of pages||5|
|Journal||Research in Social and Administrative Pharmacy|
|Early online date||13-Jul-2017|
|Publication status||Published - Jun-2018|
- NURSING-HOME RESIDENTS, CONTROLLED-TRIAL, MEDICATION, POLYPHARMACY, PHARMACIST, PREVENTION, CRITERIA, OUTCOMES, PATIENT, ADULTS